Thank you, Cabinet Secretary, for your statement today. It's a long list, isn't it, of things that, without question, pose a threat to the delivery of health and social care post Brexit. I was reading a Welsh NHS Confederation policy forum briefing earlier today, bringing together some of their main concerns: supply of workforce, the need for continued recognition of professional qualifications, protection of employment rights and patient rights, the need to continue to participate in EU collaborative programmes, making sure that regulatory alignment continues for the benefit of patients and the public's health, preserving reciprocal healthcare arrangements, ensuring robust co-ordination mechanisms on public health—it's a long, long list of areas and we couldn't possibly address all of them here today.

I don't know if you, Angela Burns, want to accuse me of mischief making also for being concerned about these areas, but coming off the back of Andrew R.T. Davies, the Welsh Conservative leader's totally inappropriate comments yesterday on Airbus, accusing them of making threats, you are doing yourselves a disservice and the Welsh public a disservice by being so blasé about the biggest threat that we have faced in modern times here in Wales.

Let me turn to a series of question to you, if I can, Cabinet Secretary. First of all, on the transport of medicines under Euratom and associated agreements, there are clearly two differing interpretations here. The first interpretation, held by the Association of the British Pharmaceutical Industry and also others working in the NHS, is that a 'no deal' Brexit is highly dangerous for patients, given the short shelf lives of the products we're talking about, making the need for seamless transport across borders essential. This makes it impossible to stockpile medicines and so on. The second interpretation held by the UK Government is that the nuclear safeguards Bill passing through Parliament now means that there is no problem. So, which interpretation do you agree with and what are your contingency plans for a 'no deal' Brexit if you agree with that first interpretation?

Secondly, turning to access to research networks and funding, what proactive steps—proactive steps—has your Government taken to ensure that our universities and our life sciences sector can continue to participate in these networks in the event of a hard Brexit? Or perhaps your Government is content to let the UK Government take those proactive steps. 

On staffing, one issue that's particularly concerning to us is the fact that we have no data on the social care and independent sector workforce, and how that will be placed at risk through a hard Brexit. So, what steps are you taking to collect and evaluate this data? 

Finally, my fourth question: we have to look at the indirect impact of things on the NHS; do you think that there's a threat to the NHS from different outcomes in trade negotiations, for example?